Australian Technical Advisory Group on Immunisation (ATAGI)

Australian Technical Advisory Group on Immunisation (ATAGI) meeting agenda.

Page last updated: 07 June 2016

Australian Technical Advisory Group on Immunisation (ATAGI) 60th Meeting - June 2016

Agenda – Day 1

Item Purpose
1.0 Welcome and Apologies and general committee business
1.1 Conflict of Interest and Confidentiality Information
1.2 Actions arising from previous meeting Information
1.3 Out of session items including correspondence Information
2.0 Recap on Industry Day Discussion
3.0 Influenza vaccine
3.1 Endorse advice on influenza vaccine for submission to Pharmaceutical Benefits Advisory Committee (PBAC) Endorse
3.2 Discussion of Influenza Industry Briefing Presented on 15 June 2016 Discussion
4.0 Pneumococcal vaccine
4.1 Membership of Pneumococcal Working Party and Conflict of Interest (CoI) Review Process Note
4.2 Endorse Advice on Pneumococcal Vaccine for Post Submission Advice to PBAC Endorse
4.3 Endorse the principal positions for updated evidence-based recommendations of pneumococcal vaccine use for younger Aboriginal and Torres Strait Islander adults Endorse
5. Pertussis Vaccine
5.1 Review Terms of Reference of Pertussis Working Party and CoI Process Endorse
5.2 Endorse Advice on a pertussis-containing vaccine for Post Submission Advice to PBAC Endorse
6.0 Department / Committees’ Updates  
6.1 Department of Health Update Information
6.2 Therapeutic Goods Administration / Advisory Committee on the Safety of Vaccines (TGA/ACSOV) Update Information
6.3 Report on Previous and Upcoming Pharmaceutical Benefits Advisory Committee Meetings Discussion
6.4 Communicable Diseases Network Australia (CDNA) Report and Epidemiology of Vaccine Preventable Diseases Information
9.0 BCG Supply Discussion
8.0 NCIRS Report Information
Meeting closed

Agenda – Day 2

Agenda item
Recap of day one
PBAC advice for Pneumococcal, Influenza and Pertussis Vaccines Endorse
10.0) Australian Immunisation Handbook
10.1) Discussion of 2017 Handbook Update Discuss
10.2) Report of the Australian Immunisation Handbook Working Party Discuss
11.0) ATAGI Strategic Directions  
12.0) Report from other Working Parties  
12.1) HPV Working Party – Review of updated epidemiology of HPV disease in Australia1 Endorse
12.2)  Special Risk Groups Working Party – Membership and Terms of Reference Endorse
12.3) Meningococcal W joint Working Group with CDNA Information

13.0 Report from Chair and Members on ATAGI Business

 
13.1 WA Mumps workshop Discuss
13.2 Report on International meeting of National Immunization Technical Groups, Annecy, May 2016 Information
13.3) ATAGI Work Plan Information

7.0 Australian Institute of Health and Welfare (AIHW) Presentation on Burden of Vaccines-Preventable Diseases (VPDs)

Information
14.0) Other Business Discuss
Meeting closed

Endorse = a decision is to be made at this meeting
Discussion = a decision is to be made at a future meeting or out of session
Information = no decision points at this stage


  1. This item will also cover presentation of preliminary summary information of 2-dose studies of the 9 valent HPV vaccine, however, it is not possible to publish this.